Tharimmune Inc. (THAR)
NASDAQ: THAR
· Real-Time Price · USD
2.85
-0.11 (-3.72%)
At close: Sep 09, 2025, 2:09 PM
-3.72% (1D)
| Bid | 2.84 |
| Market Cap | 13.21M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -12.01M |
| EPS (ttm) | -6.06 |
| PE Ratio (ttm) | -0.47 |
| Forward PE | -4.91 |
| Analyst | Buy |
| Ask | 2.94 |
| Volume | 810,796 |
| Avg. Volume (20D) | 10,083,545 |
| Open | 2.83 |
| Previous Close | 2.96 |
| Day's Range | 2.75 - 3.14 |
| 52-Week Range | 0.95 - 9.08 |
| Beta | 1.59 |
About THAR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol THAR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for THAR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
-20.75%
Tharimmune shares are trading lower after the comp...
Unlock content with
Pro Subscription
2 weeks ago
+38.44%
Tharimmune shares are trading higher following recent pharmacokinetic simulation results for its lead drug candidate TH104.
